Clinical Trial Details

EORTC-22114-40111-GITCG-ROG

Back to Clinical Trials Database

Trial of preoperative therapy for gastric and esophagogastric junction adenocarcinoma. A randomized phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 13-Nov-2013
Date Step1 close: 01-Jul-2021
Data management at EORTC No
Design Phase 2-3
Randomized open label
Targeted Sample size EORTC Groups: 211 - All Groups: 570
Treatment Radiotherapy
Study Staff Karin Haustermans (Study Coordinator) , U.Z. Leuven - Campus Gasthuisberg, Leuven
Florian Lordick (Study Coordinator) , Universitaetsklinikum Leipzig UCCL-Krebszentrum, Leipzig
Carolina Fernandes (Clinical Operations Manager) , EORTC Headquarters, Brussels
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels
Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels
Axelle Nzokirantevye (Data Manager) , EORTC Headquarters, Brussels
Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Type of cancer Gastric
Participating groups EORTC Gastrointestinal Tract Cancer Group
EORTC Radiation Oncology Group
Australasian Gastro-Intestinal Trials Group
Trans-Tasman Radiation Oncology Group Inc
Recruiting centers AZ Turnhout - Campus Sint Elisabeth (Turnhout, Belgium)
Asklepios Tumorzentrum Hamburg AK Barmbek (Hamburg, Germany)
CHRU de Besancon - Hopital Jean Minjoz (BESANCON CEDEX, France)
CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
Centre Hospitalier Regional Verviers (East Belgium) (Verviers, Belgium)
Hopital Nord Franche-Comte - Site du Mittan (Montbeliard, France)
Hospital Clinico Universitario De Valencia (Valencia, Spain)
Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
Institut Sainte Catherine (AVIGNON CEDEX 9, France)
Institut de Cancerologie Strasbourg Europe (formar Paul Strauss) (Strasbourg, France)
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany)
MVM MbH -Onkologie UnterEms, Leer-Papenburg-Emden (Leer, Germany)
Rambam Health Care Campus, Oncology Institute (Haifa, Israel)
Staedtisches Klinikum Braunschweig gGmbH (Braunschweig, Germany)
The Institute Of Oncology (Ljubljana, Slovenia)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitaetsklinikum Leipzig UCCL-Krebszentrum (Leipzig, Germany)
Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Hospital Hradec Kralove (Hradec Kralove, Czech Republic)
Protocol summary http://clinicaltrials.gov/study/NCT01924819
NCT number NCT01924819
Financial Support Academic Fund